Weekly growth hormone shot could replace daily injections for short kids

NCT ID NCT07226089

Recruiting now Disease control Sponsor: Rabin Medical Center Source: ClinicalTrials.gov ↗

Summary

This study compares a new weekly growth hormone injection (Somatrogon) against the standard daily injection (Genotropin) in children with short stature. It involves 254 children aged 3-11 who were born small for their gestational age or have unexplained short stature. The goal is to see if the weekly treatment works as well as daily injections for increasing growth rate over 12 months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Assaf Harofe Medical Center
NOT_YET_RECRUITING

Rishon LeZiyyon, Israel

Contact Email: •••••@•••••
Dana-Duek children's hospital
NOT_YET_RECRUITING

Tel Aviv, Israel

Contact Phone: •••-•••-•••• Email: •••••@•••••
Schneider Children Medical Center- the institute of Endocrinology and Diabetes
RECRUITING

Petah Tikva, Israel, 4920235, Israel

Contact Phone: •••-•••-•••• Email: •••••@•••••
Shaare Zedek Medical Center
NOT_YET_RECRUITING

Jerusalem, Israe, 9103102, Israel

Contact Email: •••••@•••••
Sheba Medical Center
NOT_YET_RECRUITING

Ramat Gan, Israel

Contact Email: •••••@•••••
Soroka hospital
NOT_YET_RECRUITING

Bear Sheva, Israel

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ISS SGA